In addition, other publicly available data from The Cancer Genome Atlas (TCGA) (7, 8) showed that lower expression of MLL4 was significantly associated with both lower expression of ALOX12 and higher expression of GPX4 in human head and neck SCC as well as bladder cancer (Fig. 4G). Here, KMT2D is linked to urinary bladder cancer.